Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Hepatitis C virus (HCV) associated liver disease has affected an estimated 180 million people worldwide, and it continues to be the most common indication for liver transplantation.

Special Feature: Telaprevir, Boceprevir for HCV: High Cost may warrant 'criteria for use' policies